The Benefit/Risk Ratio: A Handbook for the Rational Use of Potentially Hazardous Drugs
Hans Christian Körting, Monika Schäfer‐Korting · 1998
The Role and Analysis of Benefit and Risk in the Development of New Drugs, C. Chuang-Stein Prediction of the Benefit/Risk Ratio from In Vitro Data, R. Shrivastava, C. Bonnabry, and G. John Evaluation of Therapeutic Benefits and Toxicological Risks Using Structure-Activity Relational Expert Systems, H.S. Rosenkranz, G. Klopman, and O.T. Macina Improving the Therapeutic Index Through Unusual Routes of Application: Intra-Arterial Treatment of Liver Metastases, D. Civalleri, G. Numico, F. DeCian, and M. Esposito Establishing the Benefit/Risk Ratio with Combination Drugs, A. Thurmann and J. Hasford Improving the Therapeutic Index of Antineoplastic Agents through Additional Drugs, G. Numico, D. Civalleri, and M. Esposito Antihypertensive Agents, B. Schwartzkopff and B.E. Strauer Diuretics, J. Zhi Anti-Diabetic Drugs, P. Compagnucci and F. Santeusanio Anticonvulsant Drugs and Drugs for Parkinson's Disease, M.J. Eadie Antihistamines and Antiserotonins, G. Passalcqua and G.W. Canonica Cytokines and Immunomodulators, D.J. Peace, W. Wong, and K.T. Ferrer Non-Opioid Analgesics and Anti-Inflammatory Agents, G. Traversa and N. Magrini Toxicity Profile of Liposomal Anthracyclines, A. A. Gabizon Antibacterial Agents, R. Garraffo Antiviral Agents, J.M. Kilby Antifungal Agents, A.K. Gupta, P. De Doneker, and M. Heenen Drugs Used in Reproductive Endocrinology, J.F. Mortola Nicotine Preparations in Smoking, N.L. Benowitz and J. Pinney Systemic Drugs for Skin Diseases, H. Bocquet, L. Le Cleach, and J.-C. Roujeau Topical Liposome Drugs, H.C. Korting Topical Glucocorticoids, M. Schafer-Korting and A. Gysler Index